BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6971042)

  • 1. Intermediate dose methotrexate (IDM) in childhood acute lymphocytic leukemia in Norway. Preliminary results of a national treatment program.
    Moe PJ; Seip M; Finne PH
    Acta Paediatr Scand; 1981 Jan; 70(1):73-9. PubMed ID: 6971042
    [No Abstract]   [Full Text] [Related]  

  • 2. Intermediate dose methotrexate (IDM) in childhood acute lymphocytic leukaemia in Norway. Report on a national treatment program.
    Moe PJ; Seip M; Finne PH
    Haematologia (Budap); 1981; 14(3):257-63. PubMed ID: 6948760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of primary childhood acute lymphocytic leukemia with intermediate dose methotrexate.
    Sinks LF; Wang JJ; Freeman AI
    Haematol Blood Transfus; 1981; 26():99-107. PubMed ID: 6947942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of intermediate dose methotrexate in increased risk childhood acute lymphoblastic leukemia. A comparison of three versus six courses.
    Green DM; Brecher ML; Blumenson LE; Grossi M; Freeman AI
    Cancer; 1982 Dec; 50(12):2722-7. PubMed ID: 6958351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of radiotherapy in the management of acute lymphocytic leukemia.
    Glicksman AS; Tefft M
    Prog Clin Biol Res; 1978; 25():85-98. PubMed ID: 366627
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prophylactic central nervous system therapy in childhood leukemia and its complications].
    Tsukimoto I
    Rinsho Ketsueki; 1988 Apr; 29(4):449-56. PubMed ID: 3165476
    [No Abstract]   [Full Text] [Related]  

  • 7. [Acute juvenile lymphatic leukemia in the Netherlands: study ALL II, 1973-5; Foundation Dutch Childhood Leukemia Study Group].
    van der Does-van den Berg A; de Koning J; Reerink H; de Vries JA; van Zanen GE
    Ned Tijdschr Geneeskd; 1976 Sep; 120(36):1521-8. PubMed ID: 1067480
    [No Abstract]   [Full Text] [Related]  

  • 8. Cerebral calcifications associated with intrathecal methotrexate therapy in acute lymphocytic leukemia.
    Mueller S; Bell W; Seibert J
    J Pediatr; 1976 Apr; 88(4 Pt 1):650-3. PubMed ID: 1062546
    [No Abstract]   [Full Text] [Related]  

  • 9. Intermediate dose methotrexate (IDM) in children with acute lymphocytic leukemia (ALL). An update.
    Freeman AI
    Sangre (Barc); 1985; 30(6):1007-33. PubMed ID: 3913034
    [No Abstract]   [Full Text] [Related]  

  • 10. High-dose methotrexate-citrovorum factor rescue in the management of brain tumors.
    Djerassi I; Kim JS; Shulman K
    Cancer Treat Rep; 1977 Jul; 61(4):691-4. PubMed ID: 301782
    [No Abstract]   [Full Text] [Related]  

  • 11. Intermediate dose methotrexate (IDM) in childhood acute lymphocytic leukemia (ALL).
    Freeman AI; Brecher ML; Wang JJ; Sinks LF
    Haematol Blood Transfus; 1979; 23():115-23. PubMed ID: 296106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of acute lymphoblastic leukemia in childreq with "prophylactic" intrathecal methotrexate and intensive systemic chemotherapy.
    Haghbin M; Tan CT; Clarkson BD; Miké V; Burchenal JH; Murphy ML
    Cancer Res; 1975 Mar; 35(3):807-11. PubMed ID: 1054287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate infusions as central nervous system prophylaxis in children with acute lymphocytic leukemia: the Norwegian experience.
    Moe PJ; Holen A; Nygaard R; Glomstein A; Madsen B; Hellebostad M; Stokland T; Wefring KW; Steen-Johnsen J; Nielsen B; Hapnes C; Børsting S
    Pediatr Hematol Oncol; 2003; 20(3):187-200. PubMed ID: 12637215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic central nervous system therapy with cranial irradiation and intrathecal methotrexate in acute lymphoblastic leukemia of childhood.
    Wehinger H; Slanina J; Jacobi H; Musshoff K; Dietz V; Sauer M; Dilger M
    Strahlentherapie; 1974 Dec; 148(6):590-8. PubMed ID: 4532340
    [No Abstract]   [Full Text] [Related]  

  • 15. Repetitive low-dose radiation therapy for acute stem-cell leukemia.
    Considine B; Cook JJ; Zuelzer WW; Ravindranath Y; Lusher JM
    Int J Radiat Oncol Biol Phys; 1977; 2(3-4):257-60. PubMed ID: 266491
    [No Abstract]   [Full Text] [Related]  

  • 16. Recurrent childhood lymphocytic leukemia: clinical and cytokinetic studies of cytosine arabinoside and methotrexate for maintenance of second hematologic remission.
    Rivera G; Murphy SB; Aur RJ; Verzosa MS; Dahl GV; Mauer AM
    Cancer; 1978 Dec; 42(6):2521-8. PubMed ID: 282003
    [No Abstract]   [Full Text] [Related]  

  • 17. [Long-term therapy of acute lymphoblastic leukemia. Protocol 10-LA-72].
    Svarch E; Sackmann-Muriel F; González A; Vergara B; Eppinger-Helft M; Pavlovsky S; Fernández O; Cristo E; García O; Mendez J; Hernández P; Carnot J
    Sangre (Barc); 1982; 27(3):368-76. PubMed ID: 6961563
    [No Abstract]   [Full Text] [Related]  

  • 18. Intermittent intrathecal methotrexate and fractional radiation (M-IMFRA) plus chemotherapy in childhood leukemia.
    Mastrangelo R; Romanini A; Cellini N; Parenti D; De Renzis C; Riccardi R; Cimatti G; Malandrino R
    Tumori; 1978; 64(6):607-11. PubMed ID: 283624
    [No Abstract]   [Full Text] [Related]  

  • 19. [Disseminated necrotizing leukoencephalopathy following intrathecal methotrexate in childhood leukemia (author's transl)].
    Koga S; Fujimoto T; Hasegawa K; Sueishi K
    Fukuoka Igaku Zasshi; 1976 Jan; 67(1):24-31. PubMed ID: 1062350
    [No Abstract]   [Full Text] [Related]  

  • 20. High dose methotrexate in acute lymphocytic leukemia in childhood.
    Moe PJ; Seip M
    Acta Paediatr Scand; 1978 May; 67(3):265-8. PubMed ID: 148830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.